Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for Type 2 Diabetes
Sites in Suffolk +59 more locations
Sponsor: Sparrow Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07296484·Phase 2·Recruiting·Listed Dec 2025
Paid Clinical Trials in Virginia
Virginia has 1,928 paid clinical trials enrolling now across cities including Richmond, Charlottesville and Fairfax. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Virginia include University of Virginia Health, VCU Health and Inova Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
1,760 clinical trials
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for CRC (Colorectal Cancer)
Drug: Bevacizumab
Sites in Charlottesville, Winchester +68 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07284849·Phase 3·Recruiting·Listed Dec 2025
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for Advanced Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Charlottesville +192 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridioides Difficile Associated Disease
Sites in Richmond +134 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for Breast Neoplasms
Sites in Charlottesville, Fairfax +26 more locations
Sponsor: Eli Lilly and Company
Sex: Female·Age: 18+
Code: NCT07287098·Phase 2·Recruiting·Listed Dec 2025
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
for Carcinoma, Renal Cell
Drug: PF-08634404
Sites in Fairfax, Roanoke +107 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for Intestinal Neoplasms
Drug: PF-08634404
Sites in Richmond, Fairfax +179 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in Norfolk +69 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Charlottesville, Fairfax +43 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Fairfax, Norfolk +27 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07266441·Phase 2·Recruiting·Listed Dec 2025
A Study of Buntanetap in Participants With PD
for Parkinson's Disease (PD)
Sites in Charlottesville +26 more locations
Sponsor: Annovis Bio Inc.
Sex: All·Age: 40 - 85
Code: NCT07284784·Phase 2, Phase 3·Recruiting·Listed Dec 2025
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for Atopic Dermatitis
Sites in Falls Church +42 more locations
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT07290803·Recruiting·Listed Dec 2025
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
for Severe Hypertriglyceridemia
Drug: Solbinsiran
Sites in Roanoke, Lynchburg +27 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07269210·Phase 2·Recruiting·Listed Dec 2025
Study of DONQ52 in Active Celiac Disease
for Celiac Disease
Drug: DONQ52
Sites in Richmond, Lynchburg +53 more locations
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 75
Code: NCT07239336·Phase 2·Recruiting·Listed Nov 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
Drug: daraxonrasib
Sites in Fairfax +28 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for Advanced/Metastatic Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Richmond, South Hill +34 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227298·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for Untreated, Unresectable, or Metastatic Colorectal Cancer
Drug: Bevacizumab
Sites in Fairfax, Norfolk +43 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221357·Phase 2, Phase 3·Recruiting·Listed Oct 2025
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
for Obesity
Drug: Semaglutide
Sites in Richmond, Manassas +25 more locations
Sponsor: Kailera
Sex: All·Age: 18+
Code: NCT07284979·Phase 3·Recruiting·Listed Dec 2025
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
for Hidradenitis Suppurativa
Drug: Ritlecitinib
Sites in Forest +39 more locations
Sponsor: Pfizer
Sex: All·Age: 18 - 75
Code: NCT07228390·Phase 2·Recruiting·Listed Nov 2025
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
for Obesity With Diabetes
Sites in Richmond, Manassas +37 more locations
Sponsor: Kailera
Sex: All·Age: 18+
Code: NCT07284901·Phase 3·Recruiting·Listed Dec 2025
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for Dystonia
Sites in Richmond +36 more locations
Sponsor: Vima Therapeutics
Sex: All·Age: 18 - 65
Code: NCT07304089·Phase 2·Recruiting·Listed Dec 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Salem +33 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Fairfax +48 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for Non-small Cell Carcinoma
Sites in Winchester, Salem +195 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
for Peripheral Arterial Disease
Drug: Orforglipron
Sites in Richmond, Lynchburg +30 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07223593·Phase 3·Recruiting·Listed Nov 2025
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
Sites in Richmond, Fairfax +64 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07220083·Phase 3·Recruiting·Listed Oct 2025
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Norfolk +61 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: Pegcetacoplan
Sites in Lynchburg +77 more locations
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Fairfax +28 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sites in Richmond, Norfolk +139 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
Drug: Brenipatide
Sites in Fairfax +29 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Charlottesville, Norfolk +35 more locations
Sponsor: Amgen
Sex: Male·Age: 18+
Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for Alzheimers Disease
Sites in Richmond, Fairfax +66 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07177352·Phase 3·Recruiting·Listed Sep 2025
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
Drug: Muvalaplin
Sites in Richmond, Norfolk +128 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Fairfax +115 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: Coramitug
Sites in Richmond, Norfolk +58 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07207811·Phase 3·Recruiting·Listed Oct 2025
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for Ovarian Cancer
Drug: INCB123667
Sites in Charlottesville, Fairfax +45 more locations
Sponsor: Incyte Corporation
Sex: Female·Age: 18+
Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Duvakitug
Sites in Richmond, Lynchburg +92 more locations
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for Obesity
Drug: Eloralintide
Sites in Richmond, Norfolk +24 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07215559·Phase 2·Recruiting·Listed Oct 2025
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
Drug: LY4268989
Sites in Richmond, Roanoke +38 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025